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Abstract
Physiological regulations of energy balance and body weight imply highly adaptive mechanisms which match caloric intake
to caloric expenditure. In the central nervous system, the regulation of appetite relies on complex neurocircuitry which
disturbance may alter energy balance and result in anorexia or obesity. Deoxynivalenol (DON), a trichothecene, is one of the
most abundant mycotoxins found on contaminated cereals and its stability during processing and cooking explains its
widespread presence in human food. DON has been implicated in acute and chronic illnesses in both humans and farm
animals including weight loss. Here, we provide the first demonstration that DON reduced feeding behavior and modified
satiation and satiety by interfering with central neuronal networks dedicated to food intake regulation. Moreover, our
results strongly suggest that during intoxication, DON reaches the brain where it modifies anorexigenic balance. In view of
the widespread human exposure to DON, the present results may lead to reconsider the potential consequences of chronic
DON consumption on human eating disorders.
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Introduction
The capacity to adjust food intake in response to changing
energy requirements is essential for survival. Recent progress has
provided an insight into the central regulation of energy balance
that links changes of body fat stores to adaptive adjustments of
feeding behavior [1]. In the central nervous system (CNS), the
regulation of appetite relies on complex neurocircuitry. Discrete
neuronal pathways within specific brain areas, mainly the
hypothalamus and the brainstem, are clearly involved in this
control of feeding behavior. Peripheral information linked to fat
deposit or nutriment availability are implicated as endogenous
signaling molecules in the control of energy expenditure, and
initiation and termination of a meal. The primary targets of these
peripheral molecules are first-order anorexigenic and orexigenic
neurons that express pro-opiomelanocortin (POMC)/cocaine- and
amphetamine-regulated transcript (CART) and neuropeptide Y
(NPY)/Agouti-related peptide (AgRP) respectively. The physio-
logical importance of this homeostatic control system is highlight-
ed by the severe eating disorders (obesity, anorexia, cachexia) that
result from the dysfunction or any of several of its key components.
Deoxynivalenol (DON), also commonly called vomitoxin, is a
trichothecene mycotoxin mainly produced by Fusarium fungi.
DON is one of the most abundant trichothecenes found on cereals
such as wheat, barley, oats, rye, and maize, and less often in rice
grown in Europe, America and Asia [2]. The extent of cereal
contamination is strongly associated with rainfall and moisture at
the time of flowering and with grain storage conditions. DON has
been implicated in mycotoxicoses in both humans and farm
animals. High doses toxicity of DON is characterized by a set of
symptoms including diarrhea, vomiting, leukocytosis, hemorrhage,
circulatory shock and death whereas low doses toxicity is
characterized by anorexia, reduced weight gain, diminished
nutritional efficiency, neuroendocrine changes and immunologic
effects [2]. In farm animals including poultry and ruminants,
intoxication following consumption of cereals and cereal-derived
products contaminated with DON results in feed refusal and
reduced weight gain. These symptoms lead to growth retardation
and can have great economic consequences. In humans,
epidemiological studies have reported acute illnesses including
vomiting, abdominal pain, diarrhea, headache, dizziness in
populations who have consumed Fusarium-contaminated grains
and in addition, DON is suspected to increased occurrence of
more severe diseases such as esophageal cancer [3]. The levels and
patterns of human food commodities contamination justify that
DON consumption constitutes a major issue for global public
health. A survey by Lombeart and colleagues reported the
detection of DON in 63% of 363 cereal-based infant foods [4].
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26134Similarly, a European food study carried out in 12 countries
revealed that, out of a total of 11.022 samples analyzed, more than
a half contained DON [5]. DON stability during processing and
cooking explains its widespread presence in human food.
Trichothecenes, including DON, are actually stable at 120uC,
moderately stable at 180uC, decompose within 30–40 min at
210uC [6], and autoclave processing reduces by only 12% maize
contamination [7]. In view of this widespread human exposure to
DON, studies improving our knowledge of DON toxicity remain
essential and should be conducted. While the peripheral action of
DON was extensively studied [1], data illustrating its effects on
CNS are significantly less abundant. Despite the described
modulation of feeding behavior induced by DON consumption,
the data aiming to characterize this effect are limited and the
mechanisms by which this toxin exerts its action remain largely
unknown. Accordingly, additional information are strongly needed
to more accurately understand how such a commonly encountered
toxin can so severely modify animal and human food intake.
Using a multidisciplinary approach, we accessed to mecha-
nisms underlying anorexia induced by acute DON intoxication.
In conclusion, we showed that, in addition to a peripheral action,
the toxin having reached the brain after per os administration can
act centrally and results in the impairment of anorexigenic/
orexigenic balance. These data may lead to reconsider the
consequence of the chronic consumption of low DON doses on
the development of pathophysiological alteration of food intake
behavior.
Results
1- Acute per os administration of DON alters night-time
food intake and meal microstructure
A single oral administration of DON resulted in a dose-
dependent decrease in daily food intake with a notably long-
lasting effect for the highest doses (Figure 1A). Note that 6.25,
12.5 and 25 mg/kg of DON diminished respectively by 24, 39
Figure 1. Acute per os DON administration modifies night-time food intake. A: Daily food intake (% of initial food intake) measured from 24
to 192 h after oral gavage of either water (vehicle) or DON (6.25, 12.5 and 25 mg/kg) in adult mice. B: Food intake (g), measured over the first 24 h
period, of mice having received an oral gavage of either water or DON (6.25, 12.5 and 25 mg/kg). C: Kaolin intake and regular chow intake measured
0, 24, 48, 72 and 96 h after DON (12.5 mg/kg) administration. D: Correlation of kaolin intake and chow intake by mice that received an oral gavage of
either water or DON (12.5 mg/kg). In A: ¤; *; # represent P,0.05, significantly different from vehicle-treated mice, respectively for 6.25, 12.5 and
25 mg/kg DON-treated mice. In B: *P,0.05 and **P,0.01, significantly different from vehicle-treated mice. In C: **P,0.01, significantly different from
control Kaolin intake. # P,0.05, significantly different from control chow intake.
doi:10.1371/journal.pone.0026134.g001
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administration. Food consumption measured 3, 6, 12 and 18 h
after treatment revealed that DON profoundly affected the
night-time food intake (Figure 1B). To decipher feeding
behavior analysis during DON intoxication, we quantified the
consumption of a non-nutritive substance i.e. kaolin. This
behavior, known as pica, serves as a model for the study of
nausea/emesis in rodents [8]. While mice treated with vehicle
consumed 18.3+/24.8 mg/24 h of kaolin (time 0 on
Figure 1C), 12.5 mg/kg of DON caused a significant increase
in kaolin intake (83.3+/216.2 mg/24 h; P,0.01). This behav-
ior was not observable any more 48 h post-injection, while
anorexia was still ongoing. In the DON treated-mice, daily
standard chow and kaolin intakes were not significantly
correlated (r-value:0.1). Plotting the standard chow and kaolin
intakes for the vehicle- and DON-treated animals on the same
graph revealed that these two parameters were poorly
correlated (r-value:20.47, r
2:0.22; Figure 1D). Using continu-
ous recording of food consumption (Figure 2A), we next
analyzed the effect of DON (12.5 mg/kg) administration on
meal parameters computed for each animal over all meals
during the trial period. This monitoring confirmed that DON
essentially modified food intake during the dark phase
(Figure 2A). Given the modification of nightly food intake
observed in response to DON, meal microstructure analysis was
then computed for the dark phase (0–12 h). Compared with
vehicle, DON reduced meal frequency by 27.9% (15.0+/21.3
versus 20.8+/21.7 meals/12 h, P,0.05) and meal size by
44.2%(99.4+/28.4 mg versus 178.1+/226.8 mg, P,0.01) and
increased intermeal intervals by 68%(47.5+/28.9 min versus
28.2+/23.5 min, P,0.01). During this trial period, the satiety
ratio was also increased by 40% in response to the toxin
(P,0.01; Figure 2B).
2- Brain pattern of central pathways activated in
response to DON per os administration
Central structures activated in response to per os administration
of DON were next identified using the immune detection of the
c-Fos protein. A very low basal level of c-Fos positive nuclei was
observed in the brainstem, pons and forebrain of water-treated
mice (Table 1). DON-treated mice exhibited a strong rise in the
number of c-Fos positive nuclei within the nucleus tractus
solitarius (NTS) and a moderate increase within the area
postrema (AP, Figure 3 and Table 1) and ventrolateral medulla
Figure 2. Effect of acute per os DON administration on meal microstructure. A: Graph showing meal size over 24 h after an oral gavage of
either water (vehicle, black histograms) or DON (12.5 mg/kg, red histograms) in an adult mouse. Note that the width of each bar represents the meal
duration. Time is indicated in zeitgeber time, 12 being the transition between lights on and lights off and 0 or 24 the transition between lights off and
lights on. The dark period is represented by the shaded box. B: Meal microstructure analysis performed during the dark period for mice that received
either water (white bars) or DON (12.5 mg/kg, orange bars). *P,0.05 and **P,0.01, significantly different from vehicle-treated mice.
doi:10.1371/journal.pone.0026134.g002
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exhibit any DON-induced c-Fos expression whatever the rostro-
caudal level considered (Figure 3 and Table 1). Animals
challenged with DON also displayed a strong rise in c-Fos
immunoreactivity in the lateral part of the parabrachial nucleus
(LPB) and in the locus coeruleus (LC), and a moderate-to-strong
c-Fos staining within forebrain structures such as the paraven-
tricular hypothalamus nucleus (PVN), arcuate nucleus (ARC),
median eminence (ME), bed nucleus of the stria terminalis (BST)
and central nucleus of the amygdala (CeA) (Figure 3; Table 1).
3- Phenotypic characterization of DON-activated neurons
The use of POMC-GFP transgenic mice revealed that oral
DON administration (12.5 mg/kg) significantly increased the
number of POMC neurons positive for c-Fos, both in the NTS
and in the ARC (Figure 4). Interestingly, more than 40% of
POMC neurons were found immunoreactive for c-Fos within the
NTS (Figure 4B). Similarly, the number of nesfatin-1 neurons
labeled for c-Fos in the NTS and hypothalamic nuclei (ARC,
PVN, SON) was greatly increased by the treatment (Figure 5). For
these structures, the percentage of double labeled neurons was
Table 1. c-Fos signal in brain structures of vehicle or DON-challenged mice.
per os vehicle (water) per os DON (12,5 mg/kg) icv vehicle (NaCl) icv DON (12,5 mg/kg)
Diencephalon
Subfornical organ 0/++ ++ ++ ++
Paraventricular thalamic nuclei +++ +++ ++ ++
Central nucleus of the amygdala 0/++ +++ 0/++ +
Laterodorsal part of the bed of the stria terminalis 0/++ +++ 0/++ +
Hypothalamus
Preoptic area 0/++ +/++ ++ +++
Anterior area ++ ++ ++ ++
Paraventricular nucleus 0/++ +++ ++ +++
Supraoptic nucleus ++ +++ 0/++ ++
Median eminence 0/++ ++ ++
Dorsomedian nucleus 0/+ 0/+ 0/++ +
Ventromedian nucleus 0/+ 0/+ 0/+ 0/+
Lateral area ++ ++ ++ ++
Posterior area ++ ++ ++ ++
Parasubthalamic nucleus 0/++ +++ 0/++ ++
Arcuate nucleus 0/++ ++ 0/++ +++
Brainstem
Dorsal raphe nucleus 0/+ 0/+ 0/+ 0/+
Laterodorsal tegmental nucleus ++ ++ ++ ++
Parabrachial nucleus 0/++ +++ 0/++ +++
Raphe magnus nucleus 0/+ 0/+ 0/+ 0/+
Locus coeruleus ++ +++ 0/++ +++
Motor trigeminal nucleus 0/++ ++ 0/+ 0/+
Nucleus of trapezoid body +++ +++ 0/+ 0/+
Area postrema 0/++ +/++ 0/++ +
Caudal NTS 0/++ ++ 0/++ ++
Postremal NTS 0/++ +++ 0/++ +++
Rostral NTS 0/++ +++ 0/++ +++
Dorsal motor nucleus of the vagus 0/++ + 0/++ ++
Raphe obscursus nucleus 0/+ 0/+ 0/+ 0/+
Raphe pallidus nucleus 0/+ 0/+ 0/+ 0/+
Caudal Ventolateral medulla ++ ++ 0/++ ++
Rostral ventolateral medulla ++ ++ 0/++ ++
Spinal nucleus trigeminal 0/+ 0/+ 0/+ 0/+
Other
Ependymal cells 0/+ 0/+ 0/++ ++
Choroı ¨d plexus 0/++ ++ ++ ++
0=no stained cell; +=1230 cells per section; ++=31260 cells; +++=61 and more cells. Bold indicates brain structures where c-Fos signal is significantly different
between vehicle and DON-treated mice.
doi:10.1371/journal.pone.0026134.t001
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population (Figure 5B). Finally, double immunostaining of c-Fos/
Tyrosine Hydroxylase (TH) cells in the brainstem sections revealed
that about 15% of catecholaminergic (TH-containing) neurons in
the NTS were c-Fos immunoreactive after DON treatment
(Figure 6). Note that control animals (water-treated) were virtually
devoid of double labeled cells. Using real-time RT-PCR analysis
on hypothalamic samples, we next quantified POMC, CART,
melanocortin-4 receptor (MC4R), NPY and AgRP mRNA
expression. We observed that POMC, CART and MC4R mRNA
expression strongly increased following the treatment while NPY
and AgRP mRNA remained unaffected (Figure 7).
4- Unilateral cervical vagotomy does not alter
DON-induced c-Fos expression within the brainstem
The contribution of the vagus nerve in the conveyance of DON
signaling from the gastrointestinal tract toward the brainstem was
evaluated by studying the impact of unilateral cervical vagotomy
(UCV) on DON-induced c-Fos expression within the brainstem.
Seven days before DON administration and sacrifice, animals
were given an intraperitoneal injection of Fluorogold for
verification of the lesion. The absence of the retrograde neuronal
tracer fluorogold in the cell columns of the dorsal motor nucleus
(DMNX) corresponding to the sectioned branch of the vagus
attested of the correct lesion of the nerve (Figure 7A). c-Fos
immunoreactivity within the NTS, consecutive to DON treat-
ment, was not significantly altered by UCV. Furthermore, NTS
ispsi- and contra-lateral sides did not differ significantly, whatever
the rostro-caudal NTS level analyzed (P.0.05; Figure 8).
5- Intracerebroventricular (icv) DON injection on induced
anorexia and neuronal activation
To address the possible direct central action of DON, we next
performed icv injections (lateral ventricles) of the toxin on
chronically cannulated mice. At doses ineffective at the periphery,
central DON injections dose-dependently (2–20 mg/mouse) re-
duced food intake measured during the dark phase (Figure 9A). It
should be noted that these DON doses are about 20–100 fold lower
than previously used per os administered DON doses (equivalent to
125–500 mg/mouse). Interestingly, at the dose of 20 mg/mouse,
DON reduced night-time food intake as soon as 1 h after injection
and the effect was long-lasting during the following 12 h post-
injection. Compared with vehicle, this dose decreased meal
frequency by 40.1% (15.7+/24.3 versus 9.4+/21.8 meals/12 h,
P,0.05) and meal size by 53.3% (233.0+/219.7 mg versus 108.7+/
231.4 mg, P,0.01; Figure 9B). Finally, c-Fos analysis performed
on animals centrally injected with the toxin revealed a pattern of
labeled structures quite similar to that observed in animals having
received a per os administration of the toxin (Figure 9C and Table 1).
c-Fos labeling was indeed observed within the NTS, AP, LPB, LC
and hypothalamic nuclei including ME, ARC and PVN. Central
DON injection resulted also in a significant increase in c-Fos
positive POMC and nesfatin-1 expressing neurons located both in
the brainstem and hypothalamus (Figure 9C).
Discussion
The mechanisms underlying the modulation of food intake
behavior by DON and its central targets are until now unclear. To
Figure 3. Effects of per os DON administration on c-Fos immunoreactivity. A: Representative coronal sections illustrating the c-Fos labeling
observed within brainstem, pons and forebrain regions of mice treated with DON (12.5 mg/kg) and sacrificed 3 h post-treatment. Inserts show the
level and the location where the photomicrographs originate from B: Quantification of the number of c-Fos immunoreactive nuclei within brainstem,
pons and forebrain nuclei observed in mice treated either with vehicle (water, white bars) or DON (12.5 mg/kg, orange bars). *P,0.05, **P,0.01,
***P,0.001 significantly different from vehicle-treated mice. 3V, third ventricle, AP, area postrema; ARC, arcuate nucleus; Aq, Aqueduct; cc, central
canal; CeA, central amygdala; DR, dorsal raphe; LPB, lateral parabrachial; LC, locus coeruleus; ic, insular cortex; Me5, mesencephalic trigeminal nucleus;
NTS, nucleus tractus solitarius; opt, optic tract; PVN, paraventricular nucleus; RMg, raphe magnus; ROb, raphe obscursis; RP, raphe pallidus; scp,
superior cerebellar peduncle; SON, supraoptic nucleus; X, dorsal motor nucleus of the vagus; ts, tractus solitarius; vsc, ventral spinocerebellar tract.
Scale bar: 100 mm.
doi:10.1371/journal.pone.0026134.g003
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istrations. We characterized DON intoxication by showing that
the toxin affects feeding behavior by modulating both satiety and
satiation. Using c-Fos expression mapping, we first identified that
part of neuronal pathways activated by the toxin belong to
prototypic anorexigenic pathways. Finally, by performing central
injection, we demonstrated that DON could directly act on the
brain to modify eating. This new results may lead to reconsider the
impact of chronic consumption of this toxin on human health.
Acute DON intoxication results in the alteration of satiety
and satiation
While pig was reported to be the most sensitive species to DON,
numerous in vivo and in vitro DON toxicity studies were conducted
on rodents and especially on mice which can be considered as a
good model for the study of DON toxicity [9–10] and DON-
induced anorexia [11]. The doses of DON used here are classically
employed to study acute intoxication in mice [12–13]. Per os
intoxication induced a dose-dependent reduction in daily food
intake by decreasing night-time food consumption. By performing
meal pattern analysis, which allows the continuous study of ad
libitum eating and provides a detailed description of the elements of
eating behavior, we revealed that per os DON decreased both meal
frequency (satiety) and size (satiation). The observed effect on meal
frequency was evocative of nausea-induced anorexia [14–15]. On
the other hand, the consequence of DON treatment on meal size
suggested the action of DON on meal termination mechanisms. A
reduction in meal size but not in meal frequency is classically
observed with physiological regulators that potently inhibit food
intake such as leptin [16], cholecystokinin [17], peptide YY 3–36
[18], insulin [19] or melanocortin agonists [20]. Moreover, the
clay (kaolin) intake, used here as an indicator of nausea/emesis [8],
was poorly correlated with standard chow intake. This suggesting
that malaise and nausea did not totally explain anorexia. Hence,
altogether our results revealed a complex action of DON on food
intake where DON-induced anorexia depends not only on
modification of satiety but also on satiation modulation.
DON activates central anorexigenic pathways
To date, central structures activated in response to DON were
not clearly identified. Using c-Fos staining which remains a useful
approach to identify activated neuronal groups, we revealed the
activation of key autonomic areas and hypothalamic nuclei. A
significant elevation of c-Fos immunoreactivity was also observed
in the central nucleus of the CeA and the dorsolateral division of
the BST which are involved in the integration of emotional
stimuli. This pattern is consistent with a coordinated autonomic,
endocrine, and behavioral (anorexia) response to DON.
Regardless of sometimes conflicting results and evident
interspecies differences, it was initially proposed that the toxin
modifies serotoninergic and catecholaminergic activities in the
CNS, thereby altering neurotransmission in brain structures such
as the hypothalamus, frontal cortex, and cerebellum. Accordingly,
this observed elevated brain serotonin turnover was supposed to be
responsible for the vomiting effects of DON [1]. The capacity of
serotonin receptor antagonists to prevent DON-induced emesis in
swine supported this assumption [21]. Surprisingly, it should be
noted that the serotoninergic raphe nuclei did not display any
increased c-Fos labeling in response to DON, suggesting that on
the contrary to previous assumption (see [2] for review), central
serotonin release does not significantly contribute to DON-
induced hypophagia.
Moreover, we report here that a significant proportion of the
DON-activated neurons belong to central pathways strongly
dedicated to the control of food intake. These cell groups include
POMC- and nesfatin-1-expressing neurons located both in key
hypothalamic nuclei and NTS. The demonstration of POMC-
expressing neurons activation is crucial since these neurons are
well recognized to intervene in normal energy homeostasis both in
rodents and humans [22]. POMC neurons which co-express
Figure 4. Impact of per os DON administration on POMC
neurons activation. A: Representative photomicrographs of POMC-
GFP (green) and c-Fos (red) double labeling performed on hypotha-
lamic and brainstem coronal sections of mice treated with DON. Inserts
show high magnification images of double-labeled neurons. B:
Quantification of the number of POMC-GFP positive neurons (white
bars) and c-Fos double-labeled cells (gray bars) in the NTS and ARC after
DON treatment. The orange bars represent the percentage of double-
labeled neurons in each area. All immunostaining were obtained from
animals sacrificed 3 h after a 12.5 mg/kg DON administration. 3V, third
ventricle; AP, area postrema; ARC, arcuate nucleus; cc, central canal;
NTS, nucleus of the solitary tract; X, dorsal motor nucleus of the vagus.
Scale bars: 150 mm. **P,0.01, significantly different from vehicle-
treated mice. ns, non significantly different from vehicle-treated mice.
doi:10.1371/journal.pone.0026134.g004
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adiposity signals leptin or insulin. In these neurons, POMC is
cleaved to a-melanocyte stimulating hormones (a-MSH) which
acts on melanocortin 3 and melanocortin 4 receptors (MC3R and
MC4R) of neurons mainly located in the PNV to reduce appetite.
In accordance, endogenous and synthetic agonists for MC3R/
MC4R have been shown to cause hypophagia and weight loss in
experimental animals [23]. The catabolic action of both leptin and
insulin relies upon a-MSH signaling since the central administra-
tion of MC3R/MC4R antagonists was shown to block their
actions in the brain. Both insulin and leptin increase the activity of
anorexigenic POMC/CART neurons in the ARC. POMC/
CART neuronal population, also called ‘‘first-order neurons’’,
widely project to ‘‘second-order neurons’’ located in the PVN, the
LHA, the DMH and to areas of the hindbrain involved in satiation
and satiety control [24–25]. The POMC/CART-originating tract
has an overall catabolic effect whose increased activity induces a
decrease in food intake and increased energy expenditure.
Similarly, Nesfatin–1, an 82 amino-acid peptide derived from
the cleavage of the precursor NUCB2, was identified in 2006 by
Oh-I and colleagues [26]. This peptide exerts potent anorexigenic
action after either peripheral or central administration [26]. The
interest generated by this peptide is based on its anorexigenic
action performed independently of leptin signalization after
injection in both the cerebral ventricles [26] and the peritoneal
cavity [27]. Nesfatin-1 was found expressed in neurons of various
brain areas including hypothalamic nuclei (PVN, ARC) and at the
brainstem level (NTS, DMNX) [28–29]. Nesfatinergic neurons
located in these structures are activated in response to refeeding or
intraperitoneal injection of CCK suggesting that central nesfatin-1
could participate in the meal termination mechanisms [30].
Moreover, Nesfatin-1 has a food intake-reducing effect that is
Figure 5. Nesfatin-1 and c-Fos double immunochemistry performed on DON-treated mice. A: Co-detection of nesfatin-1 expressing
neurons (green) and c-Fos (red) positive cells on brainstem and hypothalamic coronal sections of mice treated with DON. Note the presence of
double-labeled neurons (inset). B: Quantification of the number of nesfatin-1-positive neurons (white bars) and c-Fos double-labeled cells (gray bars)
in the NTS, ARC, PNV and SON after DON treatment. The orange bars represent the percentage of double labeled neurons per phenotype in each
area. All immunostaining were obtained from animals sacrificed 3 h after a 12.5 mg/kg DON administration. Inserts show high magnification images
of double labeled neurons. 3V, third ventricle; AP, area postrema; ARC, arcuate nucleus; cc, central canal; PVN, paraventricular nucleus; NTS, nucleus of
the solitary tract; SON, supraoptic nucleus; TH, tyrosine hydroxylase; X, dorsal motor nucleus of the vagus. Scale bars: 200 mm. **P,0.01, significantly
different from vehicle-treated mice. ns, non significantly different from vehicle-treated mice.
doi:10.1371/journal.pone.0026134.g005
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The observation of DON-induced POMC and nesfatin–1
expressing neurons activation suggest that the release of these
anorexigenic signals and related compounds could partake in the
feeding reducing action of the toxin. Strengthening these results,
we observed that DON modulated mRNA levels of the
hypothalamic melanocortinergic pathway including POMC,
CART and MC4R, whereas mRNA of orexigenic effectors i.e.
NPY and AgRP remained unaffected. Interestingly, POMC and
CART mRNA expression is increased in response to leptin while
they are reduced in fasted or obese (ob/ob or db/db) animals [32].
Hence, these results confirmed that in response to DON
intoxication anorexigenic pathways are recruited. Finally, DON
activated brainstem/hypothalamus connecting networks as attest-
ed by the activation of the A2/C2 catecholaminergic group.
Altogether, these data strongly support the assumption that DON
interferes directly or indirectly with neuronal networks devoted to
central energy balance and that this action could partly explain the
DON-induced hypophagia and the modification of meal frequen-
cy and size we observed in response to the toxin.
DON can directly target the brain
While we reported the activation of central neurocircuitry in
response to per os DON administration, the question is how does
DON signal to the brain? The stimulation of the vagus nerve by
DON itself or peripheral compounds released in response to the
toxin could be assumed. To investigate whether per os DON
administration and probable consecutive mucosal gastric irritation
signal to the brain through vagal terminals innervating the
gastrointestinal tract, we submitted mice to UCV. UCV,
previously used to consider the contribution of the vagus nerve
to c-Fos expression within the NTS in response to various
conditions [33–34], failed to reduce DON-evoked c-Fos expression
in the ipsilateral NTS of all animals which excludes the
involvement of the vagal pathway in the DON-related information
conveyed from the gut to the brain, at least in our experimental
model and at the DON doses used. This puzzling result pointed
out the existence of an alternative, non characterized mechanism
supporting the anorexigenic action of the toxin. We hypothesized
a possible action on specific central structures of the orally
Figure 6. Effect of per os DON administration on brainstem A2/C2 neurons activation. A: Visualization of TH-expressing neurons (green)
and c-Fos (red) positive cells on brainstem coronal sections of mice treated with DON. Inserts show high magnification images of double-labeled
neurons. B: Quantification of the number of TH positive neurons (white bars) and c-Fos double-labeled cells (gray bars) in the NTS after DON
treatment. The orange bars represent the percentage of double labeled neurons per phenotype in each area. All immunostaining were obtained from
animals sacrificed 3 h after a 12.5 mg/kg DON administration. AP, area postrema; cc, central canal; NTS, nucleus of the solitary tract; TH, tyrosine
hydroxylase; X, dorsal motor nucleus of the vagus. Scale bars: 100 mm. **P,0.01, significantly different from vehicle-treated mice. ns, non significantly
different from vehicle-treated mice.
doi:10.1371/journal.pone.0026134.g006
Figure 7. Effects of per os DON administration on hypothalamic
mRNA expression. Quantification of POMC, CART, MC4R, NPY and
AgRP transcript expression within the hypothalamus of water- (white
bars) or DON-treated mice (12.5 mg/kg, orange bars). **P,0.01,
significantly different from vehicle-treated mice. ns, non significantly
different from vehicle-treated mice.
doi:10.1371/journal.pone.0026134.g007
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tricular organs. The DON-induced c-Fos staining observed in
circumventricular organs and surrounding structures (AP, NTS,
ME, ARC) supported this hypothesis. Moreover, DON was shown
to be rapidly distributed in various organs including the brain
within a short time after exposure [35]. We bring here the first
evidence showing that centrally injected DON, at doses ineffective
at the periphery, was able to dose-dependently reproduce anorexia
observed after per os intoxication. DON affected meal pattern in a
way similar to that previously observed after peripheral adminis-
tration i.e. significant decrease of meal frequency and size and
parallel increase in intermeal intervals and satiety ratio. Interest-
ingly, the pattern of activated structures was similar after per os and
icv administration and central DON injection also resulted in the
activation of anorexigenic networks including POMC and
nesfatin–1 expressing neurons both in the NTS and hypothalamus.
The mechanism by which DON activates neuronal networks
remains however to be clarified but its action seems faster than
would be expected from its inhibitory effect on protein synthesis.
DON has been reported to modulate the immune system in
murine models and to increase cytokine production in both in vitro
and in vivo murine models (see [2] for review). It is likely that pro-
inflammatory mediators could partake in the anorexigenic
response to the toxin. In accordance, we recently reported that
per os DON administration induced an up-regulation of IL-1b, IL-
6 and TNF-a mRNA within central structures involved in food
intake control [36]. The induction of such pro-inflammatory
cytokines within the brain may explain the DON-induced
anorexia observed here. A similar increased cytokine expression
was indeed observed during anorexigenic immune challenge [37].
In summary, the present work provides the first demonstration
that DON modifies feeding behavior by interfering with central
neuronal networks dedicated to food intake regulation. Moreover,
our results, with particular attention to icv DON injection,
strongly suggest that DON reaches the brain where it modifies
anorexigenic circuitry activity. These results were obtained with an
animal model using acute intoxication with relatively high DON
doses. Accordingly, extrapolation on human health should be
made with caution. However, we believe these new results are
sufficient to reconsider the impact of DON on human population
chronically exposed to low toxin doses. The consequences of a
possible central energy balance modulation should be evaluated,
especially on vulnerable and predisposed individuals suffering
from unwanted body weight loss (such as cachexia) or eating
disorders (such as anorexia nervosa). Using animal models, future
investigations will in particular determine whether chronic
consumption of low DON doses worsens such eating disorders.
Finally, these points should be addressed in the future for DON
alone and consumed in combination with other toxins that may be
present in human food.
Materials and Methods
Animal housing
Experiments were performed on adult male DBA/1lac J mice of
20–25 g body weight (Janvier). All animals were individually
Figure 8. Effect on vagotomy on brainstem DON-induced c-Fos expression. A: Detection of fluorogold (yellow) and c-Fos (red) on
brainstem coronal sections of sham or unilaterally vagotomized (UCV) mice after an oral administration of DON (12.5 mg/kg). Note that after
vagotomy no fluorogold labeling can be visualized on the ipsilateral DMNX. B: Quantification of DON-induced (12.5 mg/kg) c-Fos immunoreactivity
in subareas of the NTS in sham (grey bars) or vagotomized (purple bars) mice.
doi:10.1371/journal.pone.0026134.g008.
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12/12-h light/dark cycle (lights on at 7 am) with standard powder
diet (AO4 P2.5, SAFE UAR) and water available ad libitum.
Individual cages were designed in order to limit spillage [38]. Mice
had free access to standard powder diet via two holes made at the
bottom of the cage. For habituation, animals were housed in these
cages at least 10 days before experiments. All experiments were
performed at 21uC. Additional experiments were performed using
male proopiomelanocortin (POMC)-Tau-Topaz GFP transgenic
mice developed by Pinto and collaborators [39] using the BAC
transgenic technology.
Ethics Statement
Experiments carried out in this study were performed in strict
accordance with European Economic Community guidelines (86/
609/EEC) and the local committees’ recommendations (C-13-
055-6, Aix-Marseille University) for the care and use of laboratory
animals.
Per os administration of DON
One hour prior to the beginning of the dark phase, mice were
administered orally 6.25 to 25 mg/kg body weight (bw) DON (D-
0156, Sigma Chemical Co.), dissolved in 100 ml per 10 g body
weight of distilled water via gavage, using a 22 gauge intubation
needle (Popper and Sons). Prior to DON treatment, mice received
the same volume of distilled water using the similar oral
administration procedure for a habituation period of seven
consecutive days.
Surgery and intracerebroventricular injection of DON
Cannula implantation. Animals were anaesthetized by an
intraperitoneal injection of ketamine (100 mg/kg; Imalgen 1000,
Merial) and xylazine (6 mg/kg; Rompun, Bayer), and placed in a
digital stereotaxic apparatus (Model 502600, WPI) coupled to the
neurostar software (Neurostar GmbH). A 26-gauge stainless steel
cannula was implanted into the lateral ventricle at the following
coordinates: 0.3 mm posterior to bregma, 1.1 mm lateral to the
midline, and 2.6 mm ventral to the skull surface. The cannula was
secured to the skull with dental cement and sealed with removable
obturators. The animals were sutured, placed in individual cages
and allowed to recover for seven days. During this resting period,
animals were injected with physiological saline every other day for
habituation. One week post-surgery, mice were administered either
10 ml( 2ml/min) of physiological saline or DON solution at the
beginning of the dark phase. The correct cannula positioning was
checkedforeachanimalattheendofthe experimentbycresylviolet
staining of brain sections. Subgroups of mice were anaesthetized as
previously described and fixed with paraformadehyde 4% one hour
after injections for immunohistochemistry procedures.
Food intake Measurements
Powdered food consumption. One hour before lights off,
mice received either intra-esophageal or icv administration of
DON or vehicle. Immediately after treatment, a fresh supply of
pre-weighed food was given. The measurement of powdered food
intake was the same as in previous studies [33]. Food intake was
calculated as the difference between the pre-weighed and the
remaining powder measured with a precision balance (0.01 g;
Denver Instrument from Bioblock).
Continuous food intake measurements and meal pattern
analysis. To measure food intake in mice, we customized
commercially available polypropylene cages (Cage S; Charles
River Laboratories) with a feeding station allowing access to a food
jar, placed below the cage, and filled with powdered food (powder
Figure 9. Effect of intracerebroventricular DON injection.
A: Food intake of mice having received either an icv injection of saline
(vehicle) or DON at different doses (2 or 20 mg/mouse). B: Effect of icv
DON injection (20 mg/mouse) on meal parameters. C: c-Fos, nesfa-
tin21/c-Fos and POMC-GFP/c-Fos labeling on brainstem and hypotha-
lamic coronal sections 1 h after an icv injection of DON (20 mg/mouse).
Inserts in E show higher magnification images of double labeled
neurons. 3V, third ventricle; AP, area postrema; ARC, arcuate nucleus; cc,
central canal; NTS, nucleus of the solitary tract; X, dorsal motor nucleus
of the vagus. Scale bars 100 mm* P,0.05, **P,0.01 and significantly
different from vehicle-treated mice.
doi:10.1371/journal.pone.0026134.g009
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Kurokawa and colleagues [40] and designed in such a manner
that neither feces nor urine could drop onto the food jar and that
food spillage was reduced to a negligible amount. To analyze meal
pattern, the food jar was placed on a precision balance (Ohaus
Scout Pro; 200 g range; 0.01 g precision) connected to a computer
with a USB/RS232 interface. Custom software, developed with
Delphi, allowed the multiplexed continuous data acquisition from
1 to 8 cages. Time series of food jar weight data consisted in
stepwise reductions with high amplitude and high frequency
oscillations, separated by stabilized values, with low amplitude
infrequent oscillations. Analysis first proceeded through a Matlab
developed software, to filter out high frequency oscillations in food
jar weights and collect the starting time, end time and weight
amplitude of the stepwise reductions in food jar weight. Analyzed
data were exported to Excel for further analysis. Meals were
defined as stepwise reductions in food jar weight of at least 0.02 g
in amplitude (i.e. twice the balance precision) and 30 seconds in
duration.
Measurement of pica behavior (kaolin intake). Kaolin
pellets were prepared from pharmacological grade kaolin and gum
Arabic (Sigma Chemical Co) mixed at a 99:1 ratio in distilled
water. The kaolin paste was rolled and cut into pieces similar in
shape to mice chow pellets. The pellets were dried in an oven at
37uC for 72 h and then placed into individual cages. Mice were
allowed access to regular food and kaolin pellets during a 5 days
adaptation period before the beginning of the study. On the day of
the experiment the last 24 h kaolin consumption was recorded.
Mice were then administered DON (12.5 mg/kg bw) per os as
described above and kaolin intake was measured daily for the four
following days by subtracting preweighed and remaining kaolin
pellets with a precision balance (Denver Instrument from
Bioblock).
Vagotomy Surgeries
Animals were anaesthetized with an ip injection of ketamine
(100 mg/kg; Imalgen 1000, Merial,) and xylazine (6 mg/kg;
Rompun, Bayer), and unilateral cervical vagotomies (UCV) were
performed according to previously established procedures [41].
The left vagus nerve, which transfers the majority of gastrointes-
tinal signals to the CNS, was severed. In sham-operated animals,
the carotid trunk was exposed but the vagus nerve was not
touched. Verification of vagotomy was performed by injecting into
the peritoneal cavity a retrograde neuronal tracer, which is
transported to cell columns of the DMNX. Seven days before
DON administration and sacrifice, animals were given 0.5 ml
intraperitoneal injections of 0.4% Fluorogold (# FP46766A,
Interchim). Fluorogold staining was observed with a Nikon Eclipse
E600 light microscope and images were acquired using a DXM
1200 camera (Nikon) coupled to ACT-1 software. The absence of
Fluorogold staining in the left DMNX attested of the correct
sectioning of the nerve.
Quantitative RT-PCR analysis
Animals used for RT-PCR analysis were not refed after DON
administration and were sacrificed 3 h after treatment. mRNA
expression within the brainstem and the hypothalamus was
quantified as described previously [33]. Briefly, total RNA was
extracted from frozen hypothalamus using RNeasy Mini kit and
RNeasy Micro Kit (Qiagen) respectively. After RNA reverse
transcription, gene expression analysis by real time PCR was
performed using the ABI Thermocycler 7500 fast (Applied
Biosystems). The equivalent of 6.25 ng initial RNA was subjected
to PCR amplification in a 10 ml final volume using specific 2.4 mM
primers and SYBR Green PCR master mix (Applied Biosystems).
Product formation (primers in Table 2) was detected at 60uCi n
the fluorescein isothiocyanate channel. The generation of specific
PCR products was confirmed by melting-curve analysis. For each
PCR, cDNA were run in duplicate in parallel with serial dilutions
of a cDNA mixture tested for each primer pair to generate a
standard linear curve, which was used to estimate relative
quantities of gene of interest and of b-actin (internal reference
gene) mRNA.
Immunohistochemistry procedures
As mentioned for PCR analysis, per os treated-animals used for
immunostaining procedure were sacrificed 3 h after treatment
without free access to food. Animal perfusion was achieved with
10 ml of 0.1 M PBS followed by 50 ml of 4% paraformaldehyde
(PFA) in 0.1 M PBS. Brains were post-fixed for 1 h in 4% PFA at
room temperature, rinsed in PBS and then cryoprotected for 24–
48 h in 30% sucrose at 4uC. After freezing of the brains in
isopentane (240uC), coronal sections (40 mm thick) were cut on a
cryostat (Leica CM3050, France) and collected serially in PBS
(0.1 M; pH 7.4). Brains were cut from caudal brainstem
(Bregma28.24 mm) to forebrain (Bregma+0.75 mm).
c-Fos immunohistochemistry. c-Fos immunohistochemistry
was performed on free-floating sections using an anti-c-Fos rabbit
antiserum synthesized against amino acids 4–17 of human protein
(1:10000, Ab-5, Calbiochem) as previously described [41]. Briefly,
the free-floating sections were incubated 10 min in a solution
containing 0.3% H2O2 in PBS 0.1 M for quenching of endogenous
peroxidase activity. After 1 h in PBS containing 3% normal goat
serum (NGS) and 0.3% Triton X-100, sections were incubated for
48 h at 4uC in PBS containing 3% NGS, 0.3% Triton X-100 and
anti-c-Fos antibody. A biotinylated goat anti-rabbit IgG (1:400,
Vector Labs) was used as secondary antibody. After incubation with
the avidin-biotin complex (1:200, Vector Labs), horseradish
Table 2. Primers for SYBR Green assays.
Gene product RefSeq Primers
Fw Rv
AgRP NM_007427.2 AGCTTTGGCGGAGGTGCT GCGACGCGGAGAACGA
CART NM_013732.6 GCCAAGGCGGCAACTTC TCTTGCAACGCTTCGATCTG
MC4-R NM_016977.3 AAGCTGCCCAGATACAACTTATGA ACGCGCTCCAGTACCATAACA
NPY NM_023456.2 TCCGCTCTGCGACACTACAT TGCTTTCCTTCATTAAGAGGTCTG
POMC NM_008895.3 TGAACATCTTTGTCCCCAGAGA TGCAGAGGCAAACAAGATTGG
doi:10.1371/journal.pone.0026134.t002
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diaminobenzidine (DAB) as the chromogen. The reaction was
closely monitored and terminated when optimum intensity was
achieved (3–5 min) by washing the sections in distilled water. Non-
specific labeling was assessed on alternate slices that were treated
identically to the above but in which the primary antibody was
omitted. Alternatively, when associated with phenotyping labeling,
c-Fos staining was performed using an anti-c-Fos goat IgG (1:5000;
sc-52-G, Santa Cruz) and revealed by means of a donkey-Alexa 594
conjugated anti-goat IgG (1:400, A11058, Invitrogen). In these
cases, the sections were incubated 2 h at room temperature with the
secondary antibody.
Phenotypic identification. Todeterminepotentialactivation
of POMC, nesfatin-1 and TH expressing neurons within the
hypothalamus and brainstem in response to DON (12.5 mg/kg)
administration, we performed double immunohistochemistry
labeling on c-Fos stained sections. For POMC detection, we used
mice expressing the fluorescent GFP under the promoter of POMC
gene. GFP was labeled using an anti-GFP rabbit primary antibody
(1:1000, A11122, Molecular Probes). Similarly, identification of
nesfatin-1 neurons was performed by incubating sections with a
rabbit primary antibody raised against nesfatin-1 (1:10000, H-003-
22-B, Phoenix Pharmaceuticals Inc.). For TH detection purpose,
brainstem sections were incubated with an anti-TH rabbit antibody
(1:1000, MAB318, Chemicon). Each labeling was revealed using an
Alexa-488-conjugated secondary antibody (1:400, A11034,
Molecular Probes). Finally, all sections were mounted on gelatin-
coated slides,airdried, and coverslippedwith mountingmedium for
fluorescence microscope preparation (DAKO).
Microscopy, image analysis and cell count
c-Fos immunostaining was further analyzed by counting the
positive nuclei on four sections. c-Fos positive nuclei counting was
performed on photomicrographs acquired using a 10 fold lens with
a DXM 1200 Camera (Nikon) coupled to ACT-1 software. The
microscope was set at a specific illumination level, as was the
camera exposure time. c-Fos positive nuclei were then counted on
these pictures by computer-assisted morphometry using the NIH
image J software. Images were normalized by subtracting the
background determined for each structures studied. The c-Fos
stained elements were identified by setting a threshold value (140
grey levels above the background on a 0–255 intensity scale).
Counts were manually corrected for overlapping cell nuclei that
were counted by the software as single. The software-generated
counts of c-Fos stained profiles were also manually corrected by
excluding positive objects whose surface area did not exceed 10
pixels (image resolution 150 pixels/inch) corresponding to objects
with a surface equal or inferior to 3 square mm. For double
labeling, fluorescent images were first acquired on a confocal
microscope (Leica TCS SP2) using the 488-nm band of an Ar-laser
and the 543-nm band of a He/Ne-laser. Images were sequentially
acquired to check marker co-localization. Then, images were
routinely acquired with a DXM 1200 Camera (Nikon) coupled to
ACT-1 software. Fluorescent images acquired at 520 and 594 nm
were merged with phase contrast images to allow visualization of
activated neurons. For each brain structure studied and each
staining, the counts performed on 4 distinct sections from both
hemispheres were averaged.
Statistical analysis
Data are represented as mean 6 S.E.M. Comparisons between
data from vehicle- and DON-treated mice were performed using
unpaired 2-tailed Student’s t-test. One-way ANOVA were
performed for comparison between data from mice treated with
different doses of DON. Tukey’s HSD (Honestly Significant
Difference) test was used for post hoc analysis. P values less than
0.05 were considered significant. The correlations between the
kaolin and chow intakes were calculated by chi-square correlation
test.
Acknowledgments
The authors gratefully thank Patrick Sanchez for his critical help in the
development of software associated with the feeding station.
Author Contributions
Conceived and designed the experiments: JT ST AJ MD JDT. Performed
the experiments: CG MSB RJ MS CT ST LM MD. Analyzed the data:
CG MSB CT JT ML ST AJ MD JDT. Contributed reagents/materials/
analysis tools: NW JR BL. Wrote the paper: MD JDT.
References
1. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW (2006) Central
nervous system control of food intake and body weight. Nature 443: 289–95.
2. Pestka JJ (2010) Deoxynivalenol: mechanisms of action, human exposure, and
toxicological relevance. Arch Toxicol 84: 663–79.
3. Bryden WL (2007) Mycotoxins in the food chain: human health implications.
Asia Pac J Clin Nutr 16: 95–101.
4. Lombaert GA, Pellaers P, Roscoe V, Mankotia M, Neil R, et al. (2003)
Mycotoxins in infant cereal foods from the Canadian retail market. Food Addit
Contam 20: 494–504.
5. Schothorst RC, van Egmond HP (2004) Report from SCOOP task 3.2.10
"collection of occurrence data of Fusarium toxins in food and assessment of
dietary intake by the population of EU member states". Subtask: trichothecenes.
Toxicol Lett 153: 133–43.
6. Bretz M, Beyer M, Cramer B, Knecht A, Humpf HU (2006) Thermal
degradation of the Fusarium mycotoxin deoxynivalenol. J Agric Food Chem 54:
6445–51.
7. Wolf-Hall CE, Hanna MA, Bullerman LB (1999) Stability of deoxynivalenol in
heat-treated foods. J Food Prot 62: 962–4.
8. Yamamoto K, Matsunaga S, Matsui M, Takeda N, Yamatodani A (2002) Pica in
mice as a new model for the study of emesis. Methods Find Exp Clin Pharmacol
24: 135–8.
9. Arnold DL, McGuire PF, Nera EA, Karpinski KF, Bickis MG, et al. (1986) The
toxicity of orally administered deoxynivalenol (vomitoxin) in rats and mice. Food
Chem Toxicol 24: 935–41.
10. Rotter BA, Rotter RG, Thompson BK, Trenholm HL (1992) Investigations in
the use of mice exposed to mycotoxins as a model for growing pigs. J Toxicol
Environ Health 37: 329–39.
11. Flannery BM, Wu W, Pestka JJ (2011) Characterization of deoxynivalenol-
induced anorexia using mouse bioassay. Food Chem Toxicol 49: 1863–9.
12. Pestka JJ, Amuzie CJ (2008) Tissue distribution and proinflammatory cytokine
gene expression following acute oral exposure to deoxynivalenol: comparison of
weanling and adult mice. Food Chem Toxicol 46: 2826–31.
13. van Kol SW, Hendriksen PJ, van Loveren H, Peijnenburg A (2011) The effects
of deoxynivalenol on gene expression in the murine thymus. Toxicol Appl
Pharmacol 250: 299–311.
14. West DB, Greenwood MR, Marshall KA, Woods SC (1987) Lithium chloride,
cholecystokinin and meal patterns: evidence that cholecystokinin suppresses
meal size in rats without causing malaise. Appetite 8: 221–7.
15. Porter MH, Arnold M, Langhans W (1998) Lipopolysaccharide-induced
anorexia following hepatic portal vein and vena cava administration. Physiol
Behav 64: 581–4.
16. Flynn MC, Scott TR, Pritchard TC, Plata-Salama ´n CR (1998) Mode of action
of OB protein (leptin) on feeding. Am J Physiol 275: R174–9.
17. Hsiao S, Wang CH (1983) Continuous infusion of cholecystokinin and meal
pattern in the rat. Peptides 4: 15–7.
18. le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, et al. (2006)
Attenuated peptide YY release in obese subjects is associated with reduced
satiety. Endocrinology 147: 3–8.
19. VanderWeele DA (1994) Insulin is a prandial satiety hormone. Physiol Behav
56: 619–22.
20. Zheng H, Patterson LM, Phifer CB, Berthoud HR (2005) Brain stem
melanocortinergic modulation of meal size and identification of hypotha-
lamic POMC projections. Am J Physiol Regul Integr Comp Physiol 289:
R247–58.
Mechanisms of Vomitoxin-Induced Anorexia
PLoS ONE | www.plosone.org 12 October 2011 | Volume 6 | Issue 10 | e2613421. Prelusky DB, Trenholm HL (1993) The efficacy of various classes of anti-emetics
in preventing deoxynivalenol-induced vomiting in swine. Nat Toxins 1:
296–302.
22. Garfield AS, Lam DD, Marston OJ, Przydzial MJ, Heisler LK (2009) Role of
central melanocortin pathways in energy homeostasis. Trends Endocrinol Metab
20: 203–15.
23. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD (1997) Role of
melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature
385(6612): 165–168.
24. Schwartz MW, Woods SC, Porte Jr. D, Seeley RJ, Baskin DG (2000) Central
nervous system control of food intake. Nature 404: 661–671.
25. Berthoud HR (2002) Multiple neural systems controlling food intake and body
weight. Neurosci Biobehav Rev 26(4): 393–428.
26. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, et al. (2006) Identification of
nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443: 709–12.
27. Shimizu H, Oh-I S, Hashimoto K, Nakata M, Yamamoto S, et al. (2009)
Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-
independent mechanism. Endocrinology 150: 662–71.
28. Bonnet MS, Pecchi E, Trouslard J, Jean A, Dallaporta M, et al. (2009) Central
nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus.
J Neuroinflammation 6: 27.
29. Goebel M, Stengel A, Wang L, Lambrecht NW, Tache ´ Y (2009) Nesfatin-1
immunoreactivity in rat brain and spinal cord autonomic nuclei. Neurosci Lett
452: 241–6.
30. Kohno D, Nakata M, Maejima Y, Shimizu H, Sedbazar U, et al. (2008)
Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat
hypothalamus coexpress oxytocin and vasopressin and are activated by
refeeding. Endocrinology 149(3): 1295–301.
31. Shimizu H, Ohsaki A, Oh-I S, Okada S, Mori M (2009) A new anorexigenic
protein, nesfatin-1. Peptides 30: 995–8.
32. Benoit S, Schwartz M, Baskin D, Woods SC, Seeley RJ (2000) CNS
melanocortin system involvement in the regulation of food intake. Horm Behav
37: 299–305.
33. Timofeeva E, Baraboi ED, Richard D (2005) Contribution of the vagus nerve
and lamina terminalis to brain activation induced by refeeding. Eur J Neurosci
22: 1489–501.
34. Hermann GE, Emch GS, Tovar CA, Rogers RC (2001) c-Fos generation in the
dorsal vagal complex after systemic endotoxin is not dependent on the vagus
nerve. Am J Physiol Regul Integr Comp Physiol 280: R289–99.
35. Pestka JJ, Islam Z, Amuzie CJ (2008) Immunochemical assessment of
deoxynivalenol tissue distribution following oral exposure in the mouse. Toxicol
Lett 178: 83–7.
36. Girardet C, Bonnet MS, Jdir R, Sadoud M, Thirion S, et al. (2011) Central
inflammation and sickness-like behavior induced by the food contaminant
Deoxynivalenol: A PGE2-independent mechanism. Tox Sci In press PMID.
21873375 p.
37. Pecchi E, Dallaporta M, Thirion S, Salvat C, Berenbaum F, et al. (2006)
Involvement of central microsomal prostaglandin E synthase-1 in IL-1beta-
induced anorexia. Physiol Genomics 25: 485–92.
38. Pecchi E, Dallaporta M, Jean A, Thirion S, Troadec JD (2008) mPGES-1 knock-
out mice are resistant to cancer-induced anorexia despite the absence of central
mPGES-1 up-regulation in wild-type anorexic mice. J Neuroimmunol 199:
104–14.
39. Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, et al. (2004) Rapid
rewiring of arcuate nucleus feeding circuits by leptin. Science 304: 110–115.
40. Kurokawa M, Akino K, Kanda K (2000) A new apparatus for studying feeding
and drinking in the mouse. Physiol Behav 70: 105–12.
41. Pecchi E, Dallaporta M, Charrier C, Pio J, Jean A, et al. (2007) Glial fibrillary
acidic protein (GFAP)-positive radial-like cells are present in the vicinity of
proliferative progenitors in the nucleus tractus solitarius of adult rat. J Comp
Neurol 501: 353–68.
Mechanisms of Vomitoxin-Induced Anorexia
PLoS ONE | www.plosone.org 13 October 2011 | Volume 6 | Issue 10 | e26134